We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Regulatory News: ACTICOR BIOTECH (FR0014005OJ5 - ALACT), a clinical stage biopharmaceutical company developing glenzocimab, an innovative drug for the treatment of cardiovascular emergencies...
Regulatory News: ACTICOR BIOTECH (FR0014005OJ5 - ALACT), a clinical stage biopharmaceutical company developing glenzocimab, an innovative drug for the treatment of cardiovascular emergencies...
Regulatory News: ACTICOR BIOTECH (FR0014005OJ5 - ALACT), a clinical stage biopharmaceutical company developing glenzocimab, an innovative drug for the treatment of cardiovascular emergencies...
Regulatory News: ACTICOR BIOTECH (ISIN : FR0014005OJ5 – ALACT), société biopharmaceutique au stade clinique qui développe le glenzocimab, un médicament innovant pour le traitement des urgences...
Regulatory News: ACTICOR BIOTECH (FR0014005OJ5 - ALACT), a clinical stage biopharmaceutical company developing glenzocimab, an innovative drug for the treatment of cardiovascular emergencies...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.25 | -41.6666666667 | 0.6 | 0.63 | 0.34 | 37088 | 0.40675387 | DE |
4 | -0.25 | -41.6666666667 | 0.6 | 0.63 | 0.34 | 37088 | 0.40675387 | DE |
12 | -0.43 | -55.1282051282 | 0.78 | 0.78 | 0.234 | 18496 | 0.45210568 | DE |
26 | -3.09 | -89.8255813953 | 3.44 | 4.21 | 0.234 | 87853 | 0.82845072 | DE |
52 | -5.43 | -93.9446366782 | 5.78 | 5.78 | 0.234 | 44169 | 1.23575159 | DE |
156 | -6.75 | -95.0704225352 | 7.1 | 11 | 0.234 | 16020 | 1.99373683 | DE |
260 | 0.11 | 45.8333333333 | 0.24 | 11 | 0.11 | 66574 | 1.21754526 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions